XL Innovate

XL Innovate

XL Innovate launched in 2015 as a standalone venture capital firm seeded by AXA SA, the Paris-based insurance giant, with Mike McGavick — then CEO of AXA's XL Catlin division — installing Tom Hutton as managing partner. The firm's structure is unusual: a corporate-sponsored VC that operates with full partnership economics and independent investment authority, rather than as a strategic business unit. McGavick and Hutton set out to back founders rewriting the core infrastructure of insurance. The fund targets early-stage and Series A companies across the full insurance value chain — underwriting platforms, claims automation, distribution, and actuarial data science. Portfolio holdings have included New York-based Slice Labs, which built on-demand insurance microservices; London's Cytora, which applies machine learning to commercial underwriting risk; and Cape Analytics, a geospatial intelligence startup automating property risk assessment. XL Innovate concentrates capital in 8-12 portfolio companies per fund, taking board seats and leading rounds rather than participating as a passive co-investor. The firm operates from Menlo Park, placing it physically within the venture ecosystem rather than near AXA's corporate centers in Paris or Bermuda. Its investment committee draws on insurance operating experience across property & casualty, life reinsurance, and specialty lines. In 2018, following AXA's acquisition of XL Group and the subsequent IPO preparations, McGavick stepped back from day-to-day operations but the fund continued deploying independently. Hutton and partner Chris Downer have led the most recent investment activity. What distinguishes XL Innovate structurally is its dual identity: it carries a global insurance carrier's strategic intelligence — pricing data, claims-frequency patterns, regulatory exposure across jurisdictions — while operating with a venture fund's speed and compensation model. No other insurance-backed venture platform runs with equivalent independence. The firm must eventually resolve its succession architecture: whether it raises external LP capital, re-ups from AXA alone, or evolves into a sector-specialist GP raising from institutional allocators directly.